Drit Dula, a third-year student at RIT Kosovo, is the founder of Light Networks, a company focused on providing tailored network solutions that help businesses optimize their operations. Drit’s ...
Interim safety analysis of the randomized phase III PELICAN trial evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine as first-line therapy for metastatic breast cancer This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results